Leadership: Page 23
-
PharmaVoice Team/PharmaVoice
Overcoming the Challenges that Hinder Innovation
PharmaVOICE 100 honorees discuss the challenges that the industry needs to overcome to support future innovation. Between 2009 and 2014, the annual growth rate for the top 25 life-sciences companies slowed from the prior decade’s double-digit average to only 1% annually, according to a recent rep...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Innovation In a Patient-Centric World
From healthcare reform to the push for value in medicines to personalized healthcare, the patient is now at the center of, well, everything. This means that pharmaceutical companies are now required to create a new paradigm, with the patient at the center. An initiative that began last year withi...
By PharmaVoice Team • Aug. 1, 2015 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Letter from the Editor
In the rare disease community there is saying: Alone we are rare, together we are strong. Wendy White, senior VP, for rare diseases, at Dohmen Life Science Services, a board member of Global Genes, and the president of the Heathcare Businesswomen’s Association (HBA), shared her personal rare dis...
By Taren Grom • June 1, 2015 -
PharmaVoice Team/PharmaVoice
2015 HBA Luminaries
The Importance of Mentoring and Sponsorship Emily Lightfoot. AmerisourceBergen. Relationships with mentors have been the key to my career success. Having an advocate and coach to help me plan my career, discover my strengths, and identify opportunities has helped me develop confidence to take on ...
By Taren Grom • May 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotechnology Pool Mary Thistle Dimension Names Chief Business Officer Dimension Therapeutics, a rare disease company advancing novel treatments for diverse genetic disorders of the liver based upon an AAV gene therapy platform, has appointed Mary Thistle to the newly created position of chief bu...
By PharmaVoice Team • April 1, 2015 -
PharmaVoice Team/PharmaVoice
Innovations: Platforms
Creating Custom Multichannel Customer Engagement Cegedim’s Hub Helps Sales Reps Simplify Complex Digital Mix In these challenging times of shrinking prescriber access, pharmaceutical marketers need to determine a meaningful digital channel mix to engage their customers right out of the gate. Cege...
By PharmaVoice Team • April 1, 2015 -
PharmaVoice Team/PharmaVoice
On the Calendar
Coming Attractions Denice Torres, president of McNeil Consumer Healthcare, a Johnson & Johnson company, has been named the Healthcare Businesswomen’s Association’s 2015 Woman of the Year (WOTY). She will be honored at the 26th Woman of the Year event at the New York Hilton Midtown on Thursday...
By PharmaVoice Team • March 1, 2015 -
PharmaVoice Team/PharmaVoice
Gen Y - Gen How
Whether you want to hire them or sell them a product, meeting the needs of Millennials requires new strategies. As the newest generation of healthcare consumers and employment pool, the Gen Y population — all 77 million of them — want you to know something. They want to be happy, they want to ...
By Robin Robinson • Feb. 1, 2015 -
PharmaVoice Team/PharmaVoice
Year in Preview: On the Horizon: Looking Ahead…
Experts from across all sectors of the industry provide their input on the trends in 2015 that will have the biggest impact on the industry, and how they will shape the future of healthcare. For this year’s special Year in Preview issue we took a slightly different tact than in years past. We are...
By Taren Grom • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS The mHealth Summit, Dec. 7-11, convenes an array of healthcare stakeholders focused on the integration of mHealth and wireless solutions to improve systemic healthcare systems, patient outcomes, and acces...
By PharmaVoice Team • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Dr. Rob Kotin Seeing the Big Picture in Gene Therapy Driven to innovate by Curiosity One of the most influential thought leaders in gene therapy today, Rob Kotin, Ph.D.’s work has the potential to make a lasting impact on the lives of patients suffering from debilitating diseases of the central n...
By PharmaVoice Team • Nov. 6, 2014 -
PharmaVoice Team/PharmaVoice
A New Era of Collaboration: Knowledge Sharing
To innovate in an efficient, cost-effective, and timely manner in today’s drug development environment, companies won’t be able to go it alone; they will need to share data and collaborate in new ways. There was a time when a drugmaker would own and guard every aspect of its research and developm...
By PharmaVoice Team • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including special discounts Coming Attractions The Healthcare Businesswomen’s Assocation is holding its annual conference at the Chicago Hilton, Nov. 12-14, 2014. The conference ‚- Inspired Leaders. Powering Innovation. ‚- is expected draw more than 1...
By PharmaVoice Team • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
ACA Expands Pharma Market
Prescription drug coverage through the ACA’s health exchanges includes 8 million patients. While this is an opportunity for the pharmaceutical industry, it also puts more focus on value, costs, and outcomes. Pharmaceutical companies are finding a changed market for prescription drugs now that con...
By PharmaVoice Team • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Clinical Trial Solutions: The Upside of Clinical Solutions
Even as pharmaceutical companies and their development partners continue to grapple with bringing safe products to market on time and on budget, new technologies, models, and analytics are driving improvements to counter the industry’s challenges. According to R&D leaders who recently partici...
By PharmaVoice Team • May 29, 2014 -
PharmaVoice Team/PharmaVoice
The Change Agents
The Change Agents Jessica BruEggeman Changing Health Behavior with Insight and Compassion Passionate and knowledgeable about her belief that changing health behavior can lead to improved health outcomes, Jessica Brueggeman succeeds in making a believer out of anyone who comes within her sphere of...
By PharmaVoice Team • July 29, 2013 -
PharmaVoice Team/PharmaVoice
The Entrepreneurs
The Entrepreneurs Amy Ellis Fearless Innovation Drawing on her highly successful new product development skills in consumer products, Amy Ellis embarked on an ambitious journey: to resolve one of the industry’s most intractable problems, the unsustainably high rate of inconclusive CNS trials. Wit...
By PharmaVoice Team • July 29, 2013 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 - Who's on the List by Section
The Commanders & Chiefs David Berry Pronutria Damian Braga Sanofi Pasteur David Bruggeman Clinical Research Advantage Walter Capone The Multiple Myeloma Research Foundation Steve Collis AmerisourceBergen Corp. Nick Colucci Publicis Healthcare Communications Group Jim Curtis Remedy Health Medi...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
2013 PharmaVOICE 100 - Who's on the List by Company
2013 PharmaVOICE 100 – Who’s on the List by Company Indexed by Company Affiliation Accelrys Ken Rapp Acorda Therapeutics Denise Duca Acurian Kristin Gross Addgene Dr. Joanne Kamens Advanced Clinical Concepts David Rear Agano Solutions and Auditgraph Mauricha Marcussen AmerisourceBergen Corp. Stev...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter from the Editor By Taren Grom The 2013 PharmaVOICE 100 Each year we have the privilege of showcasing 100 of the most inspiring and motivational individuals throughout the life-sciences industry. This special issue, now in its ninth year, once again showcases the individuals as identified b...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Count Down to the Sunshine Act
Count Down to Sunshine Act The final rule for tracking physician payments under the Sunshine Act has provided needed clarity, but questions remain about data accuracy and the public’s ability to interpret the information. The pharmaceutical industry now has some guidance on how to report payments...
By Denise Myshko • May 29, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
June 17-18 Gross to Net Accounting Forum for Pharmaceutical Manufacturers Hyatt Harbor Side, Boston Institute for International Research, iirusa.comJune 17-19 Next-Gen Kinase Inhibitors The Revere Hotel, Boston Cambridge Healthtech Institute, healthtech.com/kin/ June 18 5th Annual Cloud Slam 2013...
By Heather Hummel • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Medical Affairs: The Catalyst for Effective Medical Communications
It has been said knowledge is power. Throughout the ages, healthcare professionals have been revered as powerful not only for their medical acumen but for the ability to heal the sick. Today as therapeutic options become more complex, physicians need to continually update and expand their knowled...
By Debra Joyce • March 28, 2013 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Medical Affairs: Beyond the Science
Beyond the Science By Taren Grom Medical affairs professionals are integral to creating new bridges that cross internal departments and connect to new stakeholders to share the increasing amount of scientific information available. With the current healthcare system requiring more data, quality e...
By Taren Grom • March 28, 2013 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Outsourcing: Outsourcing For Efficiency
Outsourcing for Efficiency For many sponsor companies in the life-sciences industry engaging with outsourcing partners — from the clinic to the market — is imperative if they want to drive efficiencies in time, money, and personnel as well as innovation. Life-sciences companies can reap the many ...
By Taren Grom • Jan. 28, 2013
Previous
